Medicare Part D coverage · labetalol hydrochloride · RxCUI 896983
labetalol hydrochloride 400 MG Oral Tablet
Per the CMS 2026 Part D formulary file, labetalol hydrochloride 400 MG Oral Tablet is covered by 2,652 Medicare Part D plans (52.5% of enrollable products), averaging Tier 2, with prior authorization required on 0% of covering formularies.
- 52.5%
- Plan coverage
- 2,652
- Plans covering
- T2
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for labetalol hydrochloride 400 MG Oral Tablet
Per the CMS 2026 Part D formulary file, labetalol hydrochloride 400 MG Oral Tablet (RxNorm concept RXCUI 896983, generic name labetalol hydrochloride) appears on 40 distinct formulary files spanning 2,652 Medicare Part D plan offerings - 52.5% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.
Real-world access to labetalol hydrochloride 400 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 242,891 Part D beneficiaries filled labetalol hydrochloride 400 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $46,193,048 and an average per-beneficiary annual cost of $190.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry labetalol hydrochloride 400 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 40
- Plans covering
- 2,652
- Coverage rate
- 52.5%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 242,891
- Total spending
- $46,193,048
- Avg per beneficiary
- $190.18
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering labetalol hydrochloride 400 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T1 | No | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T1 | No | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T1 | No | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is labetalol hydrochloride 400 MG Oral Tablet covered by Medicare Part D?
Yes, labetalol hydrochloride 400 MG Oral Tablet is covered by 2,652 Medicare Part D plans (52.5% of all Part D formularies).
What tier is labetalol hydrochloride 400 MG Oral Tablet on Medicare Part D plans?
labetalol hydrochloride 400 MG Oral Tablet averages Tier 2 across Part D plans, ranging from Tier 1 to Tier 6.
Does labetalol hydrochloride 400 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for labetalol hydrochloride 400 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on labetalol hydrochloride 400 MG Oral Tablet?
In 2023, total Medicare Part D spending on labetalol hydrochloride 400 MG Oral Tablet was $46,193,048, covering 242,891 beneficiaries. The average spend per beneficiary was $190.18.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- amoxicillin 40 MG/ML / clavulanate 5.7 MG/ML Oral Suspension T2
- mefloquine hydrochloride 250 MG Oral Tablet T2
- phenytoin 50 MG Chewable Tablet T2
- propafenone hydrochloride 150 MG Oral Tablet T2
- albuterol 0.417 MG/ML Inhalation Solution T2
- {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Orquidea 28 Day] T2
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA